State Of Alaska, Department Of Revenue Eton Pharmaceuticals, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.79 Billion
- Q3 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 1,421 shares of ETON stock, worth $26,387. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,421Holding current value
$26,387% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
91Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$53.1 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$37.7 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$24.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$21.8 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$11 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $470M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...